Melanoma Industry, March 2015 Market Reports from Top Publishers

You might be interested in: Drug, Diagnostic Test, Oncology, Antibody, Biomarker, Clinical Trial, Diagnostics.


 
1-10 of about 100 reports for Melanoma

Purchase Reports From Reputable Market Research Publishers

Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth

Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth

  • $ 4 995
  • Industry report
  • September 2014
  • by GBI Research

Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth Summary GBI Research, a leading business intelligence provider, has released its latest ...

Melanoma Partnering 2010-2015

Melanoma Partnering 2010-2015

  • $ 995
  • Industry report
  • March 2015
  • by Currentpartnering

The Melanoma Partnering 2010-2015 report provides understanding and access to the melanoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in melanoma partnering ...

Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Metastatic Melanoma - Pipeline Review, H1 2015

Metastatic Melanoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Metastatic Melanoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. ...

Melanoma Drug Pathway Analyzer 2015

Melanoma Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 303 targeted molecular therapies known to affect more than 251 specific intracellular signaling pathways ...

Melanoma Drug Pipeline Update 2015

Melanoma Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients ...

 Melanoma-API Insights, 2014

Melanoma-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numbe ...

Metastatic Uveal Melanoma - Pipeline Review, H2 2014

Metastatic Uveal Melanoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Metastatic Uveal Melanoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Metastatic Uveal Melanoma - Pipeline Review, H2 2014’, provides an overview of the Metastatic Uveal Melanoma’s ...

Malignant Melanoma: KOL Insight

Malignant Melanoma: KOL Insight

  • $ 6 495
  • Industry report
  • October 2014
  • by Firstword Pharma

Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline ...

About 3 000 reports for Melanoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • May 2014
    20 pages
  • Cancer  

    Oncology  

    Melanoma  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.